Distributions in CEA Doubling Time Differ in Patients with Recurrent Colorectal Carcinomas

Hepato-Gastroenterology

Volumn 51, Issue 55, 2004, Pages 147-151

  Yamamoto, Manabu ^a,b,g   Maehara, Yoshihiko ^c   Sakaguchi, Yoshihisa ^d   Mine, Hiroyuki ^b   Yamanaka, Takeharu ^e   Korenaga, Daisuke ^f   Okamura, Takeshi ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b Shin Nakama Hospital   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d FUKUOKA HIGASHI MEDICAL CENTER   (Japan)

^e KYUSHU UNIVERSITY   (Japan)

^f FUKUOKA DENTAL COLLEGE   (Japan)

^g Iki Public Hospital   (Japan)

Author keywords

CEA doubling time; Colorectal carcinoma; Distribution; Metastasis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; ASCENDING COLON; CANCER LOCALIZATION; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; COLON CANCER; COLORECTAL CARCINOMA; COLORECTAL SURGERY; DESCENDING COLON; FEMALE; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RECTUM CANCER; RECURRENT CANCER;

AGED; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS;

EID: 10744225318     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Gold P, Freedman SO: Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 1965; 121:439-462.
2. Reghavan D, Gibbs R, Costa N, Kohn J, Orr AH, Barrett A: The interpretation of marker protein assays: a Critical appraisal in clinical studies and a xenograft model. Br J Cancer 1980; 41:190-194.
3. Lewis JCM, Keep PA: Relationship of serum CEA levels to tumor size and CEA content in nude mice bearing colonic tumor xenograft. Br J Cancer 1981; 44:381-387.
4. Quayle JB: Ability of CEA blood levels to reflect tumour burden: a study in a human xenograft model. Br J Cancer 1982; 46:220-227.
5. Ahlemann LM, Staab HJ, Huebener FA: In vivo correlation of circulating CEA and tumor volume in patients with solitary metastasis. Protides Biolog Fluids 1983; 31:945-948.
6. Koga T, Kano T, Souda K, Oka N, Inokuchi K: The clinical usefulness of preoperative CEA determination in gastric cancer. Jpn J Surg 1987; 17:342-347.
7. Stamatiadis AP, Toumanidou MS, Vyssoulis GP, Manouras AJ, Apostolidis NS: Value of serum acute-phase reactant proteins and carcinoembryonic antigen in the preoperative staging of colorectal cancer. Cancer 1990; 65:2055-2057.
8. Walop W, Chrétein M, Colman NC, Fraser RS, Gilbert F, Hidvegi RS, Hutchinson T, Kelly B, Lis M, Spitzer WO, Suissa S: The use of biomarkers in the prediction of survival in patients with pulmonary carcinoma. Cancer 1990; 65:2033-2046.
9. ASCO Expert Panel T: Clinical practice guidelines for the use of tumor markers in breast and colorectal cancer: Report of the American Society of Clinical Oncology Expert Panel. J Clin Oncol 1996; 14:2843-2877.
10. Staab HJ, Anderer FA, Hornung A, Stumpf E, Fisher R: Doubling time of circulating CEA and its relation to survival of patients with recurrent colorectal cancers. Br J Cancer 1982; 46:773-781.
11. Staab HJ, Anderer FA: Growth of human colonic adenocarcinoma and development of serum CEA in athymic mice. I: Strict correlation of tumour size and mass with serum CEA concentration during logarithmic growth. Br J Cancer 1982; 46:841-847.
12. Uemura Y, Kimura T, Yoshida M, Oba N, Harada Y: Comparison of doubling times of serum carcinoembryonic antigen produced by various metastatic lesions in recurrent gastric and colorectal carcinomas. Cancer 1993; 71:4055-4059.
13. Korenaga D, Saeki H, Mawatari K, Orita H, Maekawa S, Ikeda T, Sugimachi K: Serum carcinoembryonic antigen concentration doubling time correlates with tumor biology and life expectancy in patients with recurrent gastrointestinal carcinoma. Arch Surg 1997; 132:188-194.
14. Buffill JA: Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Internal Med 1990; 113:779-788.
15. Distler P, Holt PR: Are right-and left-sided colon neoplasms distinct tumors? Dig Dis 1997; 15:302-311.
16. Potter JD: Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA 1992; 268:1573-1577.
17. Potter JD, Slattery ML, Bostick RM, Gapstur SM: Colon Cancer: a review of the epidemiology. Epidemiol Rev 1993; 15:499-545.
18. West DW, Slattery ML, Robinson LM, Schuman KL, Ford MH, Mahoney AW, Lyon JL, Sorensen AW: Dietary intake and colon cancer: sex-and anatomic site-specific associations. Am J Epidemiol 1989; 130:883-894.
19. Hirai H: A collaborative clinical study of carcinoembryonic antigen in Japan. Cancer Res 1977; 37:2267-2274.
20. Miyauchi A, Onishi T, Morimoto S, Takai S, Matsuzuka F, Kuma K, Maeda M, Kumahara Y: Relation of doubling time of plasma calcitonin levels to prognosis and recurrence of medullary thyroid carcinoma. Ann Surg 1984; 199:461-466.
21. Dixon WJ (Ed.): BMDP Statistical Software. Berkeley, CA: University of California Press, 1988.
22. Lairds Ak: Dynamics of tumor growth, comparison of growth rates and extrapolation of growth curve to one cell. Br J Cancer 1965; 19:278-291.
23. Iwatani Y, Shimada Y, Seima Y, Yamazaki T, Miyazaki N: The biological and clinicopathological characteristics of right-sided colon cancer. Oncol Rep 2000; 7:991-994.
24. Rothberg PG, Spandorfer JM, Erisman MD, Staroscik RN, Sears HF, Petersen RO, Astrin SM: Evidence that c-myc expression defines two genetically distinct forms of colorectal adenocarcinoma. Br J Cancer 1985; 52:629-632.
25. Bos JL, Feason ER, Hamilton SR, Vries MV, Boom JH, Vogelstein B: Prevalence of the ras gene mutations in colorectal cancers. Nature 1987; 327:293-297.
26. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. New Eng J Med 2000; 342:69-77.
27. Zimmer R, Thomas P: Mutations in the carcinoembryonic antigen gene in colorectal cancer patients: Implications on liver metastasis. Cancer Res 2001; 61:2822-2826.